R&D Chemsp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Hanna Katarzyna Kowalskaage 59 | 100 | $1,350.62 | 50% |
Monika Maria Kowalskaage 28 | 100 | $1,350.62 | 50% |
Hanna Katarzyna Kowalska and Monika Maria Kowalska hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2025-11-01 to 2026-05-29.
Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ArdigenS.A. | $12,513,309.89 | ardigen.com | ||
| Freshmazovia Consultingsp. z o.o. | $1,625,635.33 | freshmazoviaconsulting.pl | ||
| Oncotransfersp. z o.o. | $704,767.72 | oncotransfer.pib-nio.pl | ||
| Smart FluidS.A. | $681,963.98 | smartfluid.pl | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Innoeco Polskasp. z o.o. | $10,013.38 | innoeco.pl | ||
| NanotheaS.A. | $115.78 | nanothea.com | ||
| Ryvu TherapeuticsS.A. | – | ryvu.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-30 | Share capital increase (5,000.00 PLN → 10,000.00 PLN) | |
| 2025-09-30 | PKD change (Added: 70.20.Z) | |
| 2025-08-19 | Entered in the register |
FAQ
Last updated: 2026-10-07